These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22649695)

  • 1. Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro.
    Gribova IY; Tillib SV; Tutykhina IL; Shmarov CE; Logunov DY; Verkhovskaya LV; Naroditskii BS; Gintsburg AL
    Acta Naturae; 2011 Jul; 3(3):64-70. PubMed ID: 22649695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Camel nanoantibody" is an efficient tool for research, diagnostics and therapy].
    Tillib SV
    Mol Biol (Mosk); 2011; 45(1):77-85. PubMed ID: 21485499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingerprint-like Analysis of "Nanoantibody" Selection by Phage Display Using Two Helper Phage Variants.
    Tillib SV; Ivanova TI; Vasilev LA
    Acta Naturae; 2010 Jul; 2(3):85-93. PubMed ID: 22649655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.
    Garas MN; Tillib SV; Zubkova OV; Rogozhin VN; Ivanova TI; Vasilev LA; Logunov DY; Shmarov MM; Tutykhina IL; Esmagambetov IB; Gribova IY; Bandelyuk AS; Naroditsky BS; Gintsburg AL
    Acta Naturae; 2014 Apr; 6(2):95-105. PubMed ID: 25093116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus.
    Shmarov MM; Sedova ES; Verkhovskaya LV; Rudneva IA; Bogacheva EA; Barykova YA; Shcherbinin DN; Lysenko AA; Tutykhina IL; Logunov DY; Smirnov YA; Naroditsky BS; Gintsburg AL
    Acta Naturae; 2010 Apr; 2(1):111-8. PubMed ID: 22649637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-domain adapted antibodies against Chlamydia trachomatis, preserving the development of chlamidic infection in vitro].
    Tillib SV; Morgunova EY; Ivanova TI; Koroleva EA; Rutovskaya MV; Zigangirova NA
    Biomed Khim; 2017 Oct; 63(5):461-466. PubMed ID: 29080882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and simple method for construction of recombinant adenoviruses.
    Tan R; Li C; Jiang S; Ma L
    Nucleic Acids Res; 2006 Jul; 34(12):e89. PubMed ID: 16855284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective properties of candidate genetically engineered vaccines against avian influenza viruses constructed on the basis of recombinant adenoviral vectors].
    Sedova ES; Shmarov MM; Tutykhina IL; Barykova IuA; Verkhovskaia LV; Logunov DIu; Naroditskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (3):44-8. PubMed ID: 20734718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of adenoviral vector carrying Smad3D or Smad7].
    Qin J; Zhou Q; Qin Y; Sun Z; Zhao F; Sun Z; Wang Y; Yi C; Zhu W
    Zhongguo Fei Ai Za Zhi; 2003 Jun; 6(3):169-71. PubMed ID: 21266111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Llama nanoantibodies with therapeutic potential against human norovirus diarrhea.
    Garaicoechea L; Aguilar A; Parra GI; Bok M; Sosnovtsev SV; Canziani G; Green KY; Bok K; Parreño V
    PLoS One; 2015; 10(8):e0133665. PubMed ID: 26267898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor A(165).
    Tillib SV; Ivanova TI; Lyssuk EY; Larin SS; Kibardin AV; Korobko EV; Vikhreva PN; Gnuchev NV; Georgiev GP; Korobko IV
    Biochemistry (Mosc); 2012 Jun; 77(6):659-65. PubMed ID: 22817466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors.
    Fu S; Deisseroth AB
    Hum Gene Ther; 1997 Jul; 8(11):1321-30. PubMed ID: 9295127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prokaryotic expression of prostate-specific membrane antigen (PSMA) nanoantibody gene and screening of natural phage nanoantibody library].
    Zhang X; Chen K; Jiang K; He J; An Y; He Z; Sun F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Nov; 38(11):1030-1035. PubMed ID: 36328433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of recombinant adenovirus expressing
    Zhang H; Xu J; Cheng Y; Fu S; Liu Y; Hu Y; DU Y; Bao F
    Sheng Wu Gong Cheng Xue Bao; 2022 Sep; 38(9):3551-3562. PubMed ID: 36151821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
    Tashiro F; Niwa H; Miyazaki J
    Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and identification of a single domain antibody specific for adenovirus vectors and its application to the immunoaffinity purification of adenoviruses.
    Cheng Y; Hao Y; Bao F; Zhang H; Liu Y; Ao K; Fu S; Wu Q; Wang Z
    AMB Express; 2022 Jun; 12(1):80. PubMed ID: 35723787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
    Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
    Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of recombinant adenovirus vector with infectious adenoviral genome released from cosmid-based vector by simple procedure allowing complex manipulation.
    Kojima H; Ohishi N; Yagi K
    Biochem Biophys Res Commun; 1998 May; 246(3):868-72. PubMed ID: 9618304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.